{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Cardiovascular, Brain, and Lung Involvement in a Newborn With a Novel FLNA Mutation

Activity Steps

Description

This article has been approved by the National Association for Neonatal Nurses Certification Board for Category B credit toward recertification as an NNP.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Explain the role of filamin A (FLNA) in embryology.
  2. Analyze a combined annotation-dependent depletion (CADD) score for an FLNA mutation.
  3. Identify specific mutations in the phenotypic spectrum of FLNA alterations.

Learning Outcomes

75% of participants will demonstrate knowledge of filamin A (FLNA) mutations by achieving a minimum score of 70% on the posttest.
Price: $21.95

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.













Test Code: ANC0422
Published: April 2022
Expires: 3/7/2025
Required Passing Score: 8/10 (80%)
Authors: Giovanni Meliota, MD; Ugo Vairo, MD; Romina Ficarella; Leonardo Milella, MD; Maria Felicia Faienza, MD; Gabriele D'Amato, MD